CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 70 filers reported holding CARDIFF ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $402,922 | +190.0% | 289,872 | +206.7% | 0.00% | – |
| Q2 2023 | $138,921 | -66.3% | 94,504 | -62.2% | 0.00% | – |
| Q1 2023 | $412,175 | +49.0% | 249,803 | +26.4% | 0.00% | – |
| Q4 2022 | $276,613 | -28.3% | 197,581 | -21.1% | 0.00% | – |
| Q3 2022 | $386,000 | -50.9% | 250,468 | -29.9% | 0.00% | – |
| Q2 2022 | $786,000 | +88.0% | 357,097 | +111.7% | 0.00% | – |
| Q1 2022 | $418,000 | -90.5% | 168,656 | -76.8% | 0.00% | – |
| Q4 2021 | $4,380,000 | +51.7% | 728,524 | +68.1% | 0.00% | – |
| Q3 2021 | $2,887,000 | +9.2% | 433,336 | +9.0% | 0.00% | – |
| Q2 2021 | $2,644,000 | -59.1% | 397,461 | -43.1% | 0.00% | -100.0% |
| Q1 2021 | $6,468,000 | -73.8% | 698,549 | -49.0% | 0.00% | -66.7% |
| Q4 2020 | $24,642,000 | +378.6% | 1,369,802 | +277.5% | 0.00% | +200.0% |
| Q3 2020 | $5,149,000 | – | 362,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 2,522,083 | $15,158,000 | 12.39% |
| Octagon Capital Advisors LP | 982,753 | $5,906,000 | 1.15% |
| Altium Capital Management LP | 337,000 | $2,025,000 | 0.56% |
| ACT CAPITAL MANAGEMENT, LLC | 102,500 | $616,000 | 0.44% |
| Eventide Asset Management | 1,670,399 | $10,039,000 | 0.13% |
| Artal Group S.A. | 750,000 | $4,508,000 | 0.12% |
| Aquatic Capital Management LLC | 8,000 | $48,000 | 0.09% |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 17,300 | $104,000 | 0.06% |
| Anson Funds Management LP | 69,381 | $417,000 | 0.04% |
| KENNEDY CAPITAL MANAGEMENT LLC | 170,447 | $1,024,000 | 0.02% |